<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2018-06-17" updated="2019-12-02">
  <drugbank-id primary="true">DB14076</drugbank-id>
  <name>Interleukin-1 alpha, human recombinant</name>
  <description/>
  <cas-number/>
  <unii>8666ZWZ3E1</unii>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description/>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Organic Compounds</kingdom>
    <superclass>Organic Acids</superclass>
    <class>Carboxylic Acids and Derivatives</class>
    <subclass>Amino Acids, Peptides, and Analogues</subclass>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Dermapoietin</synonym>
    <synonym language="english" coder="">Dermatopoietin</synonym>
    <synonym language="english" coder="">Hematopoietin-1</synonym>
    <synonym language="english" coder="">IL-1 alpha</synonym>
    <synonym language="english" coder="">IL-1Î±</synonym>
    <synonym language="english" coder="">IL1 alpha</synonym>
    <synonym language="english" coder="">IL1A</synonym>
    <synonym language="english" coder="">Interleukin 1 alpha</synonym>
    <synonym language="english" coder="">SH-polypeptide-17</synonym>
  </synonyms>
  <products>
    <product>
      <name>None</name>
      <labeller>CeGaT GmbH</labeller>
      <ndc-id/>
      <ndc-product-code>71400-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-04-26</started-marketing-on>
      <ended-marketing-on>2017-05-02</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength>4 [hp_C]/2mL</strength>
      <route>Intradermal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>None</name>
      <ingredients>Interleukin-1 alpha, human recombinant</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Biological Factors</category>
      <mesh-id>D001685</mesh-id>
    </category>
    <category>
      <category>Cytokines</category>
      <mesh-id>D016207</mesh-id>
    </category>
    <category>
      <category>Intercellular Signaling Peptides and Proteins</category>
      <mesh-id>D036341</mesh-id>
    </category>
    <category>
      <category>Interleukin-1</category>
      <mesh-id>D007375</mesh-id>
    </category>
    <category>
      <category>Interleukins</category>
      <mesh-id>D007378</mesh-id>
    </category>
    <category>
      <category>Monokines</category>
      <mesh-id>D015846</mesh-id>
    </category>
    <category>
      <category>Peptides</category>
      <mesh-id>D010455</mesh-id>
    </category>
    <category>
      <category>Proteins</category>
      <mesh-id>D011506</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection</form>
      <route>Intradermal</route>
      <strength>4 [hp_C]/2mL</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>IL1A</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>